Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
키실로메타졸린
키실로메타졸린 · 자일로메타졸린 · 자일로메타졸린및그염류 · XYLOMETAZOLINE · Otrix · Otriven · Otrivin · Ba-11391

식별자 및 물리적 특성
| CAS No. | 526-36-3 |
|---|---|
| 분자식 | C16H24N2 |
| 평균 분자량 | 244.37 g/mol |
| 단동위원소 질량 | 244.19394877 g/mol |
| SMILES | Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1 |
| InChIKey | HUCJFAOMUPXHDK-UHFFFAOYSA-N |
| PubChem CID | 5709 |
| ChEMBL | CHEMBL312448 |
| ChEBI | CHEBI:10082 |
| EC No. | 208-390-6 |
| DTXSID | DTXSID8046957 |
| 현지명 | 키실로메타졸린 |
화학 및 물리적 성질
| XLogP | 3.2 |
|---|---|
| 극성 표면적 | 24.4 |
| 수소 결합 공여자 수 | 1 |
| 수소 결합 수용자 수 | 1 |
| 회전 가능 결합 수 | 3 |
| 무거운 원자 수 | 18 |
| 형식 전하 | 0 |
| 복잡도 | 302 |
| 의약품 | Pharmaceuticals -> Listed in ZINC15 |
| LogP(분배 계수) | 3.2 |
| Human Drugs | Breast FeedingLactationMilk, HumanAdrenergic alpha-AgonistsSympathomimeticsNasal DecongestantsPharmaceuticalsEar, nose and throat medicines [c] |
| 녹는점 | 317-329131 - 133 °C131-133° |
| Physical Description | Solid |
| Collision Cross Section | 161.58 Ų [M+Na]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards]170.4 Ų [M+H]+ [CCS Type: TWMethod: Major Mix IMS/Tof Calibration Kit (Waters)] |
| 끓는 점 | 394.2±21.0 °C(Predicted) |
| 밀도 | 1.00±0.1 g/cm3(Predicted) |
| 저장 조건 | Store at -20°C |
| 용해도 | DMSO: 49 mg/mL (200.51 mM)Ethanol: 49 mg/mL (200.51 mM) |
| pKa(산도 계수) | pKa 10.6±0.1(H2O t = 22.0) (Uncertain) |
| 용해도 | Water: Insoluble |
| InChI | InChI=1S/C16H24N2/c1-11-8-13(16(3,4)5)9-12(2)14(11)10-15-17-6-7-18-15/h8-9H,6-7,10H2,1-5H3,(H,17,18) |
| InChIKey | HUCJFAOMUPXHDK-UHFFFAOYSA-N |
| SMILES | C1(CC2=C(C)C=C(C(C)(C)C)C=C2C)NCCN=1 |
안전 및 규제
| 규제 정보 | Chemical: 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro- |
|---|---|
| 기타 안전 정보 | IMAP assessments - 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-: Environment tier I assessment |
| Drug Induced Liver Injury | Drug-Induced Liver Injury Severity and Toxicity (DILIst)XylometazolineDILI PositiveDOI:10.1016/j.drudis.2019.09.022 |
| Effects During Pregnancy and Lactation | ◉ Summary of Use during Lactation |
| 독성 | LD50 oral in mouse: 215mg/kg |
용도
용도
Adrenergic (vasoconstrictor).